Concepedia

Timothy S. Pardee

TS

49

Publications

4.1K

Citations

29

H-Index

1995

Active since

Affiliations

Atrium Health Wake Forest Baptist(Current)

Wake Forest University

Roswell Park Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

University of Chicago

Timothy S. Pardee is an author at Atrium Health Wake Forest Baptist specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1995–2024

49

Publications

49

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia

Heidi D. Klepin, Ann M. Geiger, Janet A. Tooze et al. · Blood · 2013 · 418 citations · Full text

Mouse models of human AML accurately predict chemotherapy response

Johannes Zuber, Ina Radtke, Timothy S. Pardee et al. · Genes & Development · 2009 · 275 citations · Full text

, , +16

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial

Angela Alistar, Bonny Morris, Rodwige Desnoyer et al. · The Lancet Oncology · 2017 · 221 citations · Full text

, , +9

The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia

Heidi D. Klepin, Ann M. Geiger, Janet A. Tooze et al. · Journal of the American Geriatrics Society · 2011 · 140 citations · Full text

Rows per page

1–5 of 49